Marinus Pharmaceuticals SG&A Expense (TTM) Insights

Marinus Pharmaceuticals Inc (MRNS)

1.17 -0.06 (-4.88%) USD | NASDAQ | Jun 28, 16:00

1.17 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	64.57M
December 31, 2023	61.15M
September 30, 2023	60.45M
June 30, 2023	58.97M
March 31, 2023	60.31M
December 31, 2022	56.84M
September 30, 2022	52.81M
June 30, 2022	48.87M
March 31, 2022	38.64M
December 31, 2021	37.28M
September 30, 2021	32.66M
June 30, 2021	27.77M
March 31, 2021	25.08M
December 31, 2020	18.55M
September 30, 2020	15.50M
June 30, 2020	13.27M
March 31, 2020	11.64M
December 31, 2019	11.46M
September 30, 2019	10.68M
June 30, 2019	10.43M
March 31, 2019	10.26M

Date	Value
December 31, 2018	8.784M
September 30, 2018	8.191M
June 30, 2018	7.689M
March 31, 2018	7.042M
December 31, 2017	6.667M
September 30, 2017	6.592M
June 30, 2017	6.55M
March 31, 2017	6.445M
December 31, 2016	6.237M
September 30, 2016	6.161M
June 30, 2016	6.01M
March 31, 2016	5.679M
December 31, 2015	5.522M
September 30, 2015	5.483M
June 30, 2015	4.973M
March 31, 2015	4.176M
December 31, 2014	3.245M
September 30, 2014	2.202M
June 30, 2014	1.647M
March 31, 2014	1.503M
December 31, 2013	1.167M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

10.68M

Minimum

Sep 2019

64.57M

Maximum

Mar 2024

37.19M

Average

37.28M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks